|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
7 April 2015 |
|
Main ID: |
NCT00004442 |
|
Date of registration:
|
18/10/1999 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Study of Bile Acids in Patients With Peroxisomal Disorders
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
September 1997 |
|
Target sample size:
|
25 |
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT00004442 |
|
Study type:
|
Interventional |
|
Study design:
|
Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Contacts
|
|
Name:
|
Kenneth Setchell |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Children's Hospital Medical Center, Cincinnati |
| | |
|
Key inclusion & exclusion criteria
|
Biochemically proven peroxisomal disorder, including:
- Zellweger syndrome
- Pseudo-Zellweger syndrome
- Neonatal adrenoleukodystrophy
- Bifunctional enzyme deficiency
- Infantile Refsum's disease
Age minimum:
N/A
Age maximum:
5 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Adrenoleukodystrophy
|
|
Zellweger Syndrome
|
|
Bifunctional Enzyme Deficiency
|
|
Infantile Refsum's Disease
|
|
Intervention(s)
|
|
Drug: cholic acid
|
|
Drug: ursodiol
|
|
Drug: chenodeoxycholic acid
|
|
Secondary ID(s)
|
|
199/13442
|
|
CHMC-C-FDR000995
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|